Table: Phoenixbio - 9-MTH group results

PhoenixBio

14/02/2019 06:30

Feb 14 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2018        Dec 31, 2017      Mar 31, 2019  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            830 mln             645 mln            1.28      
                 (+28.8 pct)         (-28.3 pct)       (+41.5 pct)  
  Operating     loss 265 mln        loss 232 mln      loss 124 mln  
  Recurring     loss 259 mln        loss 224 mln      loss 113 mln  
  Net           loss 261 mln        loss 228 mln      loss 129 mln  
  EPS          loss 89.67 yen      loss 78.68 yen    loss 44.45 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T